Name: | Description: | Size: | Format: | |
---|---|---|---|---|
124.09 KB | Adobe PDF |
Advisor(s)
Abstract(s)
Cardiovascular disease is among the main causes of mortality and morbidity worldwide. Despite significant advances in medical and interventional therapy, the prognosis of
conditions such as ischemic heart disease is still dismal. There is thus a need to investigate
new therapeutic tools, one of which is stem cell therapy. Hematopoietic stem cells are the
most studied type, and the fact that their biology is relatively well understood has led to their
being used in preclinical research and clinical trials. However, the results of some of these
studies have been controversial, which has opened the way for studies on other cell types, such
as mesenchymal stem cells. These cells have immunomodulatory properties which suggest that
they have therapeutic potential in cardiology. In the present article, the authors review the
state of the art regarding mesenchymal stem cells, from basic and translational research to
their use in clinical trials on ischemic heart disease, heart failure and arrhythmias, and discuss possible future uses.
Description
Keywords
Mesenchymal Stem Cells Cardiovascular System HSM CAR Myocardial Ischemia Heart Failure Arrhythmias
Citation
Rev Port Cardiol. 2013; 32 (1): 43-47